We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current LEGN market cap is 7.1B. The company's latest EPS is USD and P/E is N/A.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 96.01M | 137.59M | 93.99M | 186.52M | 160.21M |
| Operating Income | -92.75M | -62.93M | -117.86M | -41.97M | -71.49M |
| Net Income | -62.21M | -144.82M | -59.79M | -18.2M | -125.32M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 57.26M | 75.68M | 89.79M | 117.01M | 285.14M |
| Operating Income | -137.05M | -229.2M | -373.04M | -458.05M | -442.22M |
| Net Income | -132.97M | -303.48M | -386.21M | -446.35M | -518.25M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.84B | 1.85B | 1.78B | 1.8B | 1.74B |
| Total Liabilities | 499.7M | 597.24M | 611.05M | 639.18M | 619.72M |
| Total Equity | 1.34B | 1.25B | 1.16B | 1.16B | 1.12B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 287.72M | 721.01M | 1.12B | 1.33B | 1.85B |
| Total Liabilities | 410.58M | 440.75M | 647.16M | 586.65M | 597.24M |
| Total Equity | -122.87M | 280.26M | 471.21M | 744.31M | 1.25B |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -297.63M | -393.28M | 15.52M | 13.87M | -61.96M |
| Investing | -314.72M | 92.79M | -396.15M | -1.09B | -762.7M |
| Financing | 790.57M | 791.49M | 831k | 1.79M | 6.03M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -83.07M | -223.01M | -198.47M | -201.28M | -393.28M |
| Investing | -58.65M | -24.17M | -194.98M | -77.09M | 92.79M |
| Financing | 14.67M | 618.88M | 626.66M | 377.98M | 791.49M |
| Market Cap | 7.1B |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 181.91M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.84 (2.15%) |
| Company Name | Legend Biotech Corporation |
| Address |
4th floor, harbour place grand cayman KY1 1002 |
| Website | https://www.legendbiotech.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
